4sight Health October 25, 2023
David Burda

Healthcare middlemen like group purchasing organizations, distributors and pharmacy benefit managers (PBMs) add costs to our already bloated healthcare system, not subtract costs through savings like they claim.

If you don’t believe me, read this short but telling research letter in JAMA Health Forum. Written by four researchers affiliated with the University of Utah and Johns Hopkins University, the research letter looks at the financial impact of spread pricing by PBMs. That’s when PBMs charge health insurers more than what the PBMs pay dispensing pharmacies for the same covered drugs. PBMs keep the difference.

The researchers’ study pool consisted of 45 generic drugs covered by Medicare Part D. For a drug to be included in the pool, more than two...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Healthcare System, Pharma, Pharma / Biotech, Pricing / Spending, Survey / Study, Trends
Gene Therapy for Cardiomyopathies Presents Promising Alternative to Current Treatment
STAT+: 3 trends to watch in biotech in 2025
CVS, Walgreens & Walmart's healthcare strategy faces headwinds: 10 notes from 2024
The GLP-1 dilemma persists into 2025
The Chase for Novel Oral GLP-1 Obesity Meds Adds a New Contender

Share This Article